A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

PHASE2CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

March 5, 2020

Primary Completion Date

July 7, 2023

Study Completion Date

July 7, 2023

Conditions
Dermatitis, Atopic
Interventions
DRUG

Nemolizumab

Nemolizumab was administered by 2 SC injections as 60-mg loading dose at baseline and a single 30-mg dose at Weeks 4, 8, and 12.

DRUG

Placebo

Placebo was administered by 2 SC injections at baseline and a single dose at Weeks 4, 8, and 12.

Trial Locations (64)

11415

Galderma Investigational Site (Site#8828), Kew Gardens

19067

Galderma Investigational Site (Site#8353), Yardley

19104

Galderma Investigational Site (Site#8428), Philadelphia

21204

Galderma Investigational Site (Site#8793), Towson

27617

Galderma Investigational Site (Site#9919), Raleigh

28150

Galderma Investigational Site (Site#8795), Shelby

29407

Galderma Investigational Site (Site#8777), Charleston

32174

Galderma Investigational Site (Site#8213), Ormond Beach

Galderma Investigational Site (Site#8856), Ormond Beach

32256

Galderma Investigational Site (Site#8836), Jacksonville

32801

Galderma Investigational Site (Site#8788), Orlando

33013

Galderma Investigational Site (Site#8391), Hialeah

33014

Galderma Investigational Site (Site#9921), Miami Lakes

33063

Galderma Investigational Site (Site#8850), Margate

33122

Galderma Investigational Site (Site#8792), Doral

33135

Galderma Investigational Site (Site#8851), Miami

33172

Galderma Investigational Site (Site#8843), Sweetwater

33174

Galderma Investigational Site (Site#8856), Ormond Beach

33433

Galderma Investigational Site (SIte#8870), Boca Raton

33613

Galderma Investigational Site (Site#8764), Tampa

Galderma Investigational Site 2 (Site#8816), Tampa

33615

Galderma Investigational Site (Site#8839), Tampa

33765

Galderma Investigational Site (Site#8786), Clearwater

34761

Galderma Investigational Site (Site#8840), Ocoee

37072

Galderma Investigational Site (Site#8200), Goodlettsville

46250

Galderma Investigational Site (Site#8142), Indianapolis

48059

Galderma Investigational Site (Site#8129), Fort Gratiot

48084

Galderma Investigational Site (Site#8849), Troy

61761

Galderma Investigational Site (Site#8739), Normal

63044

Galderma Investigational Site (Site#8876), Bridgeton

66215

Galderma Investigational Site (Site#8532), Overland Park

70005

Galderma Investigational Site (Site#8812), Metairie

72916

Galderma Investigational Site (Site#8447), Fort Smith

73118

Galderma Investigational Site (Site#8857), Oklahoma City

75093

Galderma Investigational Site (Site#8787), Plano

75231

Galderma Investigational Site (Site#8245), Dallas

77004

Galderma Investigational Site (Site#8868), Houston

77494

Galderma Investigational Site (Site#8817), Katy

77598

Galderma Investigational Site (Site#8003), Webster

77702

Galderma Investigational Site (Site#8855), Beaumont

78742

Galderma Investigational Site (Site#8846), Austin

84058

Galderma Investigational Site (Site#8844), Orem

84663

Galderma Investigational Site (Site#9935), Springville

85018

Galderma Investigational Site (Site#9922), Phoenix

85260

Galderma Investigational Site (Site#8873), Scottsdale

89118

Galderma Investigational Site (Site#8847), Las Vegas

89144

Galderma Investigational Site (Site#8848), Las Vegas

Galderma Investigational Site 2 (Site#8864), Las Vegas

90045

Galderma Investigational Site (Site#8130), Los Angeles

90057

Galderma Investigational Site (Site#8813), Los Angeles

90301

Galderma Investigational Site (Site#8833), Inglewood

Galderma Investigational Site 2 (Site#8833), Inglewood

90703

Galderma Investigational Site (Site#8578), Cerritos

90806

Galderma Investigational Site (Site#8858), Long Beach

91303

Galderma Investigational Site (Site#8854), Canoga Park

91767

Galderma Investigational Site (Site#8837), Pomona

92647

Galderma Investigational Site (Site#8845), Huntington Beach

92801

Galderma Investigational Site (Site#8831), Anaheim

93720

Galderma Investigational Site (Site#8791), Fresno

97504

Galderma Investigational Site (Site#8841), Medford

48038-1137

Galderma Investigational Site (Site#8033), Clinton Township

03801

Galderma Investigational Site (Site#8420), Portsmouth

08869

Galderma Investigational Site (Site#9924), Raritan

78229-3409

Galderma Investigational Site (Site#8329), San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT04365387 - A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab | Biotech Hunter | Biotech Hunter